{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T22:32:44Z","timestamp":1786487564133,"version":"build-2736575974"},"reference-count":100,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011033","name":"Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023315","name":"Asociaci\u00f3n de Amigos de la Universidad de Navarra","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023315","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Gobierno de Espa\u00f1a Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["RYC2018-025897-I"],"award-info":[{"award-number":["RYC2018-025897-I"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004895","name":"European Social Fund Plus","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004895","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ejps.2026.107597","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T16:36:21Z","timestamp":1782923781000},"page":"107597","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["An injectable nanoreinforced hydrogel for combined GDNF-loaded nanoparticles and mesenchymal stem cell therapy in Parkinson\u2019s disease"],"prefix":"10.1016","volume":"224","author":[{"given":"Rub\u00e9n","family":"Del Campo-Montoya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Mulet i Piera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Garc\u00eda-G\u00f3mara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Alfaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Chocarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario Mart\u00ednez","family":"De Ilarduya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 L.","family":"Lanciego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Rosario","family":"Luquin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar","family":"Cuadrado-Tejedor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Garc\u00eda-Osta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda J.","family":"Blanco-Prieto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2049-4143","authenticated-orcid":false,"given":"Elisa","family":"Garbayo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2026.107597_bib0001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biomaterials.2017.05.008","article-title":"Engineered hydrogels increase the post-transplantation survival of encapsulated hESC-derived midbrain dopaminergic neurons","volume":"136","author":"Adil","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejps.2026.107597_bib0002","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3390\/genes8020063","article-title":"AAV vector-mediated gene delivery to substantia nigra dopamine neurons: implications for gene therapy and disease models","volume":"8","author":"Albert","year":"2017","journal-title":"Genes"},{"key":"10.1016\/j.ejps.2026.107597_bib0003","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1001\/jama.2019.22360","article-title":"Diagnosis and treatment of Parkinson disease: a review","volume":"323","author":"Armstrong","year":"2020","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.ejps.2026.107597_bib0004","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1177\/1877718X241301041","article-title":"Neurotrophic factors for Parkinson\u2019s disease: current status, progress, and remaining questions. Conclusions from a 2023 workshop","volume":"14","author":"Barker","year":"2024","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.ejps.2026.107597_bib0005","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.nbd.2016.01.002","article-title":"Long-term controlled GDNF over-expression reduces dopamine transporter activity without affecting tyrosine hydroxylase expression in the rat mesostriatal system","volume":"88","author":"Barroso-Chinea","year":"2016","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ejps.2026.107597_bib0006","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.stem.2013.09.006","article-title":"Mesenchymal stromal cells: sensors and switchers of inflammation","volume":"13","author":"Bernardo","year":"2013","journal-title":"Cell Stem. Cell"},{"key":"10.1016\/j.ejps.2026.107597_bib0007","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.3233\/JPD-179002","article-title":"Replacing dopamine neurons in Parkinson\u2019s disease: how did it happen?","volume":"7","author":"Bj\u00f6rklund","year":"2017","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.ejps.2026.107597_bib0008","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3389\/fnana.2015.00091","article-title":"Oxidative stress and Parkinson\u2019s disease","volume":"9","author":"Blesa","year":"2015","journal-title":"Front. Neuroanat."},{"key":"10.1016\/j.ejps.2026.107597_bib0009","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.expneurol.2012.01.011","article-title":"Axon degeneration in Parkinson\u2019s disease","volume":"246","author":"Burke","year":"2013","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ejps.2026.107597_bib0010","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/s41467-019-08858-y","article-title":"Brain tyrosinase overexpression implicates age-dependent neuromelanin production in Parkinson\u2019s disease pathogenesis","volume":"10","author":"Carballo-carbajal","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejps.2026.107597_bib0011","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/0306-4522(90)90438-A","article-title":"Retrograde axonal transport of neurotensin in the dopaminergic nigrostriatal pathway in the rat","volume":"36","author":"Castel","year":"1990","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejps.2026.107597_bib0012","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.expneurol.2005.12.021","article-title":"MRI volumetric and intensity analysis of the cerebellum in Parkinson\u2019s disease patients infused with glial-derived neurotrophic factor (GDNF)","volume":"198","author":"Chebrolu","year":"2006","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ejps.2026.107597_bib0013","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1186\/s13287-025-04675-x","article-title":"Mesenchymal stromal cell-mediated mitochondrial transfer unveils new frontiers in disease therapy","volume":"16","author":"Chen","year":"2025","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.ejps.2026.107597_bib0014","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0304-3940(98)00554-0","article-title":"Glial cell line-derived neurotrophic factor protects against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neurotoxicity in C57BL\/6 mice","volume":"252","author":"Cheng","year":"1998","journal-title":"Neurosci. Lett."},{"issue":"1","key":"10.1016\/j.ejps.2026.107597_bib0015","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-68609-y","article-title":"GDNF improves the cognitive ability of PD mice by promoting glycosylation and membrane distribution of DAT","volume":"14","author":"Chengcheng","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejps.2026.107597_bib0016","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ejpb.2017.09.014","article-title":"Secretome released from hydrogel-embedded adipose mesenchymal stem cells protects against the Parkinson\u2019s disease related toxin 6-hydroxydopamine","volume":"121","author":"Chierchia","year":"2017","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"1","key":"10.1016\/j.ejps.2026.107597_bib0017","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/s41531-026-01289-9","article-title":"Introducing PIGMO, a novel PIGmented MOuse model of Parkinson\u2019s disease","volume":"12","author":"Chocarro","year":"2026","journal-title":"Npj Parkinson\u2019s Dis."},{"key":"10.1016\/j.ejps.2026.107597_bib0018","doi-asserted-by":"crossref","first-page":"5000","DOI":"10.1093\/brain\/awad331","article-title":"Neuromelanin accumulation drives endogenous synucleinopathy in non-human primates","volume":"146","author":"Chocarro","year":"2023","journal-title":"Brain"},{"key":"10.1016\/j.ejps.2026.107597_bib0019","doi-asserted-by":"crossref","first-page":"3172","DOI":"10.4103\/NRR.NRR-D-24-00894","article-title":"A systematic review of progenitor survival and maturation in Parkinsonian models","volume":"20","author":"Comini","year":"2025","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.ejps.2026.107597_bib0020","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1097\/00001756-199807130-00039","article-title":"GDNF administration induces recovery of the nigrostriatal dopaminergic system both in young and aged parkinsonian mice","volume":"9","author":"Date","year":"1998","journal-title":"Neuroreport"},{"key":"10.1016\/j.ejps.2026.107597_bib0021","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1080\/17425247.2022.2136161","article-title":"Hydrogels for brain repair: application to Parkinson\u2019s disease","volume":"19","author":"Del Campo-Montoya","year":"2022","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ejps.2026.107597_bib0022","article-title":"Targeting neuroinflammation in Parkinson\u2019s disease: immunomodulatory effects of a hyaluronic acid-based nanoreinforced hydrogel loaded with GDNF and mesenchymal stem cells","author":"Del Campo-Montoya","year":"2025","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2026.107597_bib0023","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.neuroimage.2008.03.037","article-title":"High resolution three-dimensional brain atlas using an average magnetic resonance image of 40 adult C57Bl\/6J mice","volume":"42","author":"Dorr","year":"2008","journal-title":"Neuroimage"},{"key":"10.1016\/j.ejps.2026.107597_bib0024","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S1474-4422(18)30295-3","article-title":"Global, regional, and national burden of Parkinson\u2019s disease, 1990\u20132016: a systematic analysis for the global burden of disease study 2016","volume":"17","author":"Dorsey","year":"2018","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ejps.2026.107597_bib0025","first-page":"1","article-title":"Epidemiology of Parkinson\u2019s disease","volume":"1580","author":"Elbaz","year":"2015","journal-title":"Rev. Neurol. (Paris)"},{"key":"10.1016\/j.ejps.2026.107597_bib0026","doi-asserted-by":"crossref","first-page":"5512","DOI":"10.1038\/s41467-022-33252-6","article-title":"Small soluble \u03b1-synuclein aggregates are the toxic species in Parkinson\u2019s disease","volume":"13","author":"Emin","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejps.2026.107597_bib0027","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.tins.2025.04.005","article-title":"Neuromelanin and selective neuronal vulnerability to Parkinson\u2019s disease","volume":"48","author":"Filimontseva","year":"2025","journal-title":"Trends. Neurosci."},{"key":"10.1016\/j.ejps.2026.107597_bib0028","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.expneurol.2017.10.001","article-title":"Neuroprotection and neurorestoration as experimental therapeutics for Parkinson\u2019s disease","volume":"298","author":"Francardo","year":"2017","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ejps.2026.107597_bib0029","article-title":"Controlled release of MIF siRNA and GDNF protein from a photocurable scaffold efficiently repairs spinal cord injury","volume":"6","author":"Gao","year":"2025","journal-title":"MedComm (Beijing)"},{"key":"10.1016\/j.ejps.2026.107597_bib0030","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.biomaterials.2016.09.015","article-title":"Brain delivery of microencapsulated GDNF induces functional and structural recovery in parkinsonian monkeys","volume":"110","author":"Garbayo","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejps.2026.107597_bib0031","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1002\/mds.23793","article-title":"Long-term neuroprotection and neurorestoration by glial cell-derived neurotrophic factor microspheres for the treatment of Parkinson\u2019s disease","volume":"26","author":"Garbayo","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ejps.2026.107597_bib0032","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jconrel.2008.12.010","article-title":"Effective GDNF brain delivery using microspheres-a promising strategy for Parkinson\u2019s disease","volume":"135","author":"Garbayo","year":"2009","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2026.107597_bib0033","first-page":"1","article-title":"Neuroprotective effects of dexamethasone in a neuromelanin-driven Parkinson\u2019s disease model","volume":"20","author":"Garc\u00eda-G\u00f3mara","year":"2025","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.ejps.2026.107597_bib0034","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.ymthe.2025.01.049","article-title":"FKBP51 inhibition ameliorates neurodegeneration and motor dysfunction in the neuromelanin-SNCA mouse model of Parkinson\u2019s disease","volume":"33","author":"Garc\u00eda-G\u00f3mara","year":"2025","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ejps.2026.107597_bib0035","doi-asserted-by":"crossref","first-page":"761","DOI":"10.3390\/biom13050761","article-title":"Opposing spatially segregated function of endogenous GDNF-RET signaling in cocaine addiction","volume":"13","author":"Garton","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.ejps.2026.107597_bib0036","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s00441-020-03269-8","article-title":"GDNF clinical trials for Parkinson\u2019s disease: a critical human dimension","volume":"382","author":"Gash","year":"2020","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.ejps.2026.107597_bib0037","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2021.626128","article-title":"Molecular mechanisms underlying synaptic and axon degeneration in Parkinson\u2019s Disease","volume":"15","author":"Gcwensa","year":"2021","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.ejps.2026.107597_bib0038","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13287-023-03264-0","article-title":"Mesenchymal stromal cell-derived secretome-based therapy for neurodegenerative diseases: overview of clinical trials","volume":"14","author":"Ghasemi","year":"2023","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.ejps.2026.107597_bib0039","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.brainres.2006.07.025","article-title":"Glial cell line-derived neurotrophic factor (GDNF) enhances dopamine release from striatal nerve endings in an adenosine A2A receptor-dependent manner","volume":"1113","author":"Gomes","year":"2006","journal-title":"Brain Res."},{"issue":"5","key":"10.1016\/j.ejps.2026.107597_bib0040","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1007\/s40120-025-00793-z","article-title":"Neuroprotection in Parkinson disease","volume":"14","author":"Gonzalez-Robles","year":"2025","journal-title":"Neurol. Ther."},{"key":"10.1016\/j.ejps.2026.107597_bib0041","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/s41586-021-04059-0","article-title":"Disruption of mitochondrial complex I induces progressive parkinsonism","volume":"599","author":"Gonz\u00e1lez-Rodr\u00edguez","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ejps.2026.107597_bib0042","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1093\/brain\/awac445","article-title":"In vivo reduction of age-dependent neuromelanin accumulation mitigates features of Parkinson\u2019s disease","volume":"146","author":"Gonzalez-Sepulveda","year":"2023","journal-title":"Brain"},{"key":"10.1016\/j.ejps.2026.107597_bib0043","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.brainresbull.2021.07.016","article-title":"Restoring lost nigrostriatal fibers in Parkinson\u2019s disease based on clinically-inspired design criteria","volume":"175","author":"Gordi\u00e1n-V\u00e9lez","year":"2021","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.ejps.2026.107597_bib0044","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.neuropharm.2018.05.014","article-title":"GDNF revisited: A novel mammalian cell-derived variant form of GDNF increases dopamine turnover and improves brain biodistribution","volume":"147","author":"Grondin","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejps.2026.107597_bib0045","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/eji.201948336","article-title":"TNF-\u03b1 and IL-1\u03b2 sensitize human MSC for IFN-\u03b3 signaling and enhance neutrophil recruitment","volume":"51","author":"Hackel","year":"2021","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.ejps.2026.107597_bib0046","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jconrel.2024.03.023","article-title":"Cryogel microcarriers for sustained local delivery of growth factors to the brain","volume":"369","author":"Hakami","year":"2024","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.ejps.2026.107597_bib0047","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41392-022-00932-0","article-title":"The secretion profile of mesenchymal stem cells and potential applications in treating human diseases","volume":"7","author":"Han","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.ejps.2026.107597_bib0048","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13024-023-00676-7","article-title":"Mitochondrial dysfunction in Parkinson\u2019s disease \u2013 a key disease hallmark with therapeutic potential","volume":"18","author":"Henrich","year":"2023","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.ejps.2026.107597_bib0049","article-title":"Tissue programmed hydrogels functionalized with gdnf improve human neural grafts in Parkinson\u2019s disease","volume":"31","author":"Hunt","year":"2021","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.ejps.2026.107597_bib0050","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.3390\/cells9092113","article-title":"Hyaluronic acid biomaterials for central nervous system regenerative medicine","volume":"9","author":"Jensen","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.ejps.2026.107597_bib0051","doi-asserted-by":"crossref","first-page":"7111","DOI":"10.1523\/JNEUROSCI.17-18-07111.1997","article-title":"GDNF Protection against 6-OHDA: time dependence and requirement for protein synthesis","volume":"17","author":"Kearns","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejps.2026.107597_bib0052","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/0006-8993(94)01366-P","article-title":"GDNF protects nigral dopamine neurons against 6-hydroxydopamine in vivo","volume":"672","author":"Kearns","year":"1995","journal-title":"Brain Res."},{"key":"10.1016\/j.ejps.2026.107597_bib0053","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ebiom.2018.01.002","article-title":"Enhanced Immunosuppressive properties of human mesenchymal stem cells primed by interferon-\u03b3","volume":"28","author":"Kim","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ejps.2026.107597_bib0054","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/glia.20731","article-title":"Neuroprotective effects of human mesenchymal stem cells on dopaminergic neurons through anti-inflammatory action","volume":"57","author":"Kim","year":"2009","journal-title":"Glia"},{"key":"10.1016\/j.ejps.2026.107597_bib0055","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1523\/JNEUROSCI.1673-16.2016","article-title":"Dampened amphetamine-stimulated behavior and altered dopamine transporter function in the absence of brain GDNF","volume":"37","author":"Kopra","year":"2017","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejps.2026.107597_bib0056","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s40035-020-00221-2","article-title":"Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes","volume":"9","author":"Kwon","year":"2020","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.ejps.2026.107597_bib0057","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-024-53168-7","article-title":"Modelling human neuronal catecholaminergic pigmentation in rodents recapitulates age-related neurodegenerative deficits","volume":"15","author":"Laguna","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejps.2026.107597_bib0058","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/ana.20737","article-title":"Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease","volume":"59","author":"Lang","year":"2006","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ejps.2026.107597_bib0059","doi-asserted-by":"crossref","first-page":"427.e1","DOI":"10.1016\/j.neurobiolaging.2010.10.013","article-title":"Enhanced dopamine transporter activity in middle-aged Gdnf heterozygous mice","volume":"33","author":"Littrell","year":"2012","journal-title":"Neurobiol. Aging."},{"key":"10.1016\/j.ejps.2026.107597_bib0060","doi-asserted-by":"crossref","first-page":"4971","DOI":"10.1073\/pnas.1913904117","article-title":"The process of Lewy body formation, rather than simply \u03b1-synuclein fibrillization, is one of the major drivers of neurodegeneration","volume":"117","author":"Mahul-Mellier","year":"2020","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ejps.2026.107597_bib0061","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcyt.2025.102009","article-title":"Implantation of human mesenchymal stromal cell pellet for therapeutic angiogenesis","volume":"28","author":"Mammoto","year":"2026","journal-title":"Cytotherapy"},{"issue":"8","key":"10.1016\/j.ejps.2026.107597_bib0062","doi-asserted-by":"crossref","first-page":"3247","DOI":"10.1038\/s41380-022-01554-2","article-title":"Elevated endogenous GDNF induces altered dopamine signalling in mice and correlates with clinical severity in schizophrenia","volume":"27","author":"M\u00e4tlik","year":"2022","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.ejps.2026.107597_bib0063","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1523\/JNEUROSCI.4029-08.2009","article-title":"Single nigrostriatal dopaminergic neurons form widely spread and highly dense axonal arborizations in the neostriatum","volume":"29","author":"Matsuda","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejps.2026.107597_bib0064","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.neuroimage.2013.08.034","article-title":"Brain maturation of the adolescent rat cortex and striatum: changes in volume and myelination","volume":"84","author":"Mengler","year":"2014","journal-title":"Neuroimage"},{"key":"10.1016\/j.ejps.2026.107597_bib0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.parkreldis.2023.105448","article-title":"Neuromelanin: its role in the pathogenesis of idiopathic Parkinson\u2019s disease and potential as a therapeutic target","volume":"112","author":"Mitra","year":"2023","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.ejps.2026.107597_bib0066","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/ejn.14090","article-title":"Encapsulation of young donor age dopaminergic grafts in a GDNF-loaded collagen hydrogel further increases their survival, reinnervation, and functional efficacy after intrastriatal transplantation in hemi-Parkinsonian rats","volume":"49","author":"Moriarty","year":"2019","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.ejps.2026.107597_bib0067","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-15970-w","article-title":"Encapsulation of primary dopaminergic neurons in a GDNF-loaded collagen hydrogel increases their survival, re-innervation and function after intra-striatal transplantation","volume":"7","author":"Moriarty","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejps.2026.107597_bib0068","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/ejn.14051","article-title":"Primary tissue for cellular brain repair in Parkinson\u2019s disease: promise, problems and the potential of biomaterials","volume":"49","author":"Moriarty","year":"2019","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.ejps.2026.107597_bib0069","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbr.2014.07.045","article-title":"Effect of GDNF on depressive-like behavior, spatial learning and key genes of the brain dopamine system in genetically predisposed to behavioral disorders mouse strains","volume":"274","author":"Naumenko","year":"2014","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejps.2026.107597_bib0070","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1212\/WNL.60.1.69","article-title":"Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD","volume":"60","author":"Nutt","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.ejps.2026.107597_bib0071","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.parkreldis.2018.06.025","article-title":"Evidence for dopaminergic axonal degeneration as an early pathological process in Parkinson\u2019s disease","volume":"56","author":"O\u2019Keeffe","year":"2018","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.ejps.2026.107597_bib0072","article-title":"Inflammatory hallmarks in 6-OHDA- and LPS-induced Parkinson\u2019s disease in rats","volume":"30","author":"Oliynyk","year":"2023","journal-title":"Brain Behav. Immun. Health"},{"key":"10.1016\/j.ejps.2026.107597_bib0073","doi-asserted-by":"crossref","first-page":"3458","DOI":"10.1016\/j.neuron.2022.10.020","article-title":"Microglia states and nomenclature: a field at its crossroads","volume":"110","author":"Paolicelli","year":"2022","journal-title":"Neuron"},{"key":"10.1016\/j.ejps.2026.107597_bib0074","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.neuroimage.2014.04.001","article-title":"Waxholm space atlas of the sprague Dawley rat brain","volume":"97","author":"Papp","year":"2014","journal-title":"Neuroimage"},{"key":"10.1016\/j.ejps.2026.107597_bib0075","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/ana.20374","article-title":"Intraputamenal infusion of glial cell line-derived neurotrophic factor in PD: a two-year outcome study","volume":"57","author":"Patel","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ejps.2026.107597_bib0076","series-title":"The mouse brain in stereotaxic coordinates","author":"Paxinos","year":"2019"},{"key":"10.1016\/j.ejps.2026.107597_bib0077","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"2014"},{"key":"10.1016\/j.ejps.2026.107597_bib0078","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2017.13","article-title":"Parkinson disease","volume":"3","author":"Poewe","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.ejps.2026.107597_bib0079","article-title":"Glial cell line-derived neurotrophic factor family members reduce microglial activation via inhibiting p38MAPKs-mediated inflammatory responses","volume":"2014","author":"Rickert","year":"2014","journal-title":"J. Neurodegener. Dis."},{"key":"10.1016\/j.ejps.2026.107597_bib0080","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.nbd.2012.04.014","article-title":"Astrocyte-derived GDNF is a potent inhibitor of microglial activation","volume":"47","author":"Rocha","year":"2012","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"10.1016\/j.ejps.2026.107597_bib0081","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41531-025-00872-w","article-title":"Mapping of catecholaminergic denervation, neurodegeneration, and inflammation in 6-OHDA-treated Parkinson\u2019s disease mice","volume":"11","author":"Santoro","year":"2025","journal-title":"Npj Parkinson\u2019s Dis."},{"key":"10.1016\/j.ejps.2026.107597_bib0082","doi-asserted-by":"crossref","first-page":"614","DOI":"10.3171\/foc.2006.20.5.2","article-title":"Unilateral intraputaminal glial cell line-derived neurotrophic factor in patients with Parkinson disease: response to 1 year each of treatment and withdrawal","volume":"20","author":"Slevin","year":"2006","journal-title":"Neurosurg. Focus"},{"key":"10.1016\/j.ejps.2026.107597_bib0083","doi-asserted-by":"crossref","first-page":"216","DOI":"10.3171\/jns.2005.102.2.0216","article-title":"Improvement of bilateral motor functions in patients with Parkinson disease through the unilateral intraputaminal infusion of glial cell line-derived neurotrophic factor","volume":"102","author":"Slevin","year":"2005","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.ejps.2026.107597_bib0084","article-title":"A biocompatible therapeutic catheter-deliverable hydrogel for in situ tissue engineering","volume":"8","author":"Steele","year":"2019","journal-title":"Adv. Heal. Mater."},{"key":"10.1016\/j.ejps.2026.107597_bib0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/JPD-150769","article-title":"Retrograde axonal degeneration in Parkinson disease","volume":"6","author":"Tagliaferro","year":"2016","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.ejps.2026.107597_bib0086","doi-asserted-by":"crossref","first-page":"6618","DOI":"10.1111\/ejn.15437","article-title":"Neonatal 6-OHDA lesion of the SNc induces striatal compensatory sprouting from surviving SNc dopaminergic neurons without VTA contribution","volume":"54","author":"Tanguay","year":"2021","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.ejps.2026.107597_bib0087","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41577-022-00684-6","article-title":"Inflammation and immune dysfunction in Parkinson disease","volume":"22","author":"Tansey","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ejps.2026.107597_bib0088","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.3390\/biomedicines12102243","article-title":"Preconditioning of mesenchymal stem cells enhances the neuroprotective effects of their conditioned medium in an Alzheimer\u2019s Disease in vitro model","volume":"12","author":"Tolstova","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.ejps.2026.107597_bib0089","doi-asserted-by":"crossref","first-page":"8274","DOI":"10.1073\/pnas.92.18.8274","article-title":"Retrograde axonal transport of glial cell line-derived neurotrophic factor in the adult nigrostriatal system suggests a trophic role in the adult","volume":"92","author":"Tomac","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.ejps.2026.107597_bib0090","doi-asserted-by":"crossref","first-page":"4629","DOI":"10.1021\/acs.biomac.2c00853","article-title":"Encapsulation of MSCs and GDNF in an Injectable nanoreinforced supramolecular hydrogel for brain tissue engineering","volume":"23","author":"Torres-Ortega","year":"2022","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.ejps.2026.107597_bib0091","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2021.105726","article-title":"Optimization of a GDNF production method based on Semliki Forest virus vector","volume":"159","author":"Torres-Ortega","year":"2021","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2026.107597_bib0092","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1002\/mds.27776","article-title":"Neuromelanin, aging, and neuronal vulnerability in Parkinson\u2019s disease","volume":"34","author":"Vila","year":"2019","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ejps.2026.107597_bib0093","doi-asserted-by":"crossref","first-page":"600","DOI":"10.3390\/cells14080600","article-title":"Therapeutic potential of mesenchymal stem cell-derived extracellular vesicles in the treatment of Parkinson\u2019s disease","volume":"14","author":"Volarevic","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.ejps.2026.107597_bib0094","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.biomaterials.2015.09.039","article-title":"Functionalized composite scaffolds improve the engraftment of transplanted dopaminergic progenitors in a mouse model of Parkinson\u2019s disease","volume":"74","author":"Wang","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejps.2026.107597_bib0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0215348","article-title":"Volumes of brain structures in captive wild-type and laboratory rats: 7T magnetic resonance in vivo automatic atlas-based study","volume":"14","author":"Welniak-Kaminska","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.ejps.2026.107597_bib0096","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3233\/JPD-191576","article-title":"Extended treatment with glial cell line-derived neurotrophic factor in Parkinson\u2019s disease","volume":"9","author":"Whone","year":"2019","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.ejps.2026.107597_bib0097","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.brainres.2011.10.038","article-title":"Human bone marrow mesenchymal stem cells protect catecholaminergic and serotonergic neuronal perikarya and transporter function from oxidative stress by the secretion of glial-derived neurotrophic factor","volume":"1431","author":"Whone","year":"2012","journal-title":"Brain Res."},{"key":"10.1016\/j.ejps.2026.107597_bib0098","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/brain\/awz023","article-title":"Randomized trial of intermittent intraputamenal glial cell line-derived neurotrophic factor in Parkinson\u2019s disease","volume":"142","author":"Whone","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.ejps.2026.107597_bib0099","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.msec.2019.03.024","article-title":"An injectable conductive Gelatin-PANI hydrogel system serves as a promising carrier to deliver BMSCs for Parkinson\u2019s disease treatment","volume":"100","author":"Xue","year":"2019","journal-title":"Mater. Sci. Eng. C"},{"issue":"8","key":"10.1016\/j.ejps.2026.107597_bib0100","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/nn.4060","article-title":"Identification of a Vav2-dependent mechanism for GDNF\/Ret control of mesolimbic DAT trafficking","volume":"18","author":"Zhu","year":"2015","journal-title":"Nat. Neurosci."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098726001715?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098726001715?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T22:26:07Z","timestamp":1786487167000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098726001715"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":100,"alternative-id":["S0928098726001715"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2026.107597","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An injectable nanoreinforced hydrogel for combined GDNF-loaded nanoparticles and mesenchymal stem cell therapy in Parkinson\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2026.107597","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107597"}}